Background

• Dokter senior yang sudah berpengalaman di bidangnya
• Keahlian khusus pada lung/thoracic and head/neck cancers

• Dr Tan Chee Seng completed his advanced specialist training in medical oncology, and was awarded the Academic Medicine Development Award (AMDA) fellowship to subspecialise in personalisation of lung cancer therapies at Addenbrooke’s Hospital in the UK.
• He was a former consultant with the haematology-oncology department at the National University Cancer Institute of Singapore (NCIS) and National University Hospital (NUH), and was a visiting consultant at Ng Teng Fong General Hospital (NTFGH).
• He was previously appointed as an assistant professor and undergraduate education director in medical oncology at the Yong Loo Lin School of Medicine. He was also a core faculty member of the medical oncology senior residency at NUH.
• He is a member of several professional bodies including American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), and International Association for the Study of Lung Cancer (IASLC).
• He was the principal investigator or co-investigator for several international multi-centre cancer clinical trials including novel chemotherapy agents, targeted therapies, tyrosine kinase inhibitors, antibody-drug conjugates, and immunotherapy agents.
• He authored or co-authored publications in peer-reviewed international journals including Lancet Oncology, Clinical Cancer Research, Molecular Cancer, Lung Cancer, Oncotarget, Target Oncology, Journal of Cancer Research and Clinical Oncology, and Journal of Translational Medicine.
• Dr Tan had been invited to speak or chair in local and regional oncology meetings, and has routinely held public talks for local GPs.
• He is the recipient of several grants including National Medical Research Council (NMRC) Clinician Investigator Salary Support Programme, and Investigational Medicine Unit (IMU) Bridging Funds